During a Case-Based Roundtable event, Laura Huppert, MD, discussed data and considerations around using T-DXd in breast cancer and the need for HER2-negative data with T-DXd. For Heart Health Month, ...
The LumiSystem is now commercially available in the US for breast cancer detection. The device uses fluorescence imaging technology during lumpectomy, offering a more complete resection vs other ...
NEWTON, Mass., Jan. 27, 2025 /PRNewswire/ -- Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today ...
Unlike other detection systems that only evaluate tissue after it has been surgically removed, LumiSystemâ„¢ allows for real-time visualization of cancer inside the breast. This enables surgeons ...
Jan. 27, 2025 /PRNewswire/ -- Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today announced the U.S. commercial availability and ...